ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000223813.2	Gefitinib	Skin cutaneous melanoma	0.036462518	Resistant
ENSG00000223813.2	Gefitinib	Breast invasive carcinoma	0.00487351	Sensitive
ENSG00000223813.2	Gefitinib	Sarcoma	0.046721012	Sensitive